Curcumin Knee Pain Meta-analysis: What the Evidence Says

Quick Answer

Curcumin Knee Pain Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Non-steroidal anti-inflammatory drugs (NSAIDs), as first-line pharmacological agents, provide symptomatic improvement but are associated with gastrointestinal bleeding and cardiovascular risks upon prolonged administration. [Shi Chuankai (2026); evidence level 1]
• Systematic reviews and meta-analyses of observational studies indicate substantial heterogeneity in NSAID utilization among OA patients, with generally limited evidence quality. [Shi Chuankai (2026); evidence level 1]
• Osteoarthritis (OA) is the most common musculoskeletal disease globally, which leads to significant disability arising from reduced joint mobility, increased functional burden, and reduced quality of life. [Lopresti Adrian L. (2026); evidence level 2]
• In a recent meta-analysis, it was concluded that, based on 23 studies and 2,175 patients with knee OA, compared with placebo, oral curcumin reduced self-reported pain as measured by the visual analogue scale and the Western Ontario and McMaster Universities Arthritis Index. [Lopresti Adrian L. (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For curcumin knee pain meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Shi Chuankai (2026). Efficacy and safety of different curcumin formulations in osteoarthritis: an umbrella review of systematic reviews. DOI: 10.3389/fmed.2026.1801273. PMCID: PMC13233388. PMID: 42254374. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13233388/
• Lopresti Adrian L. (2026). The effect of a topical curcumin formulation (VAS-101) on knee pain in adults with knee osteoarthritis: a randomised, double-blind, placebo-controlled study. DOI: 10.3389/fpain.2026.1789088. PMCID: PMC13079332. PMID: 41994034. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13079332/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.